✦ LIBER ✦

Enzyme Replacement Therapy for Pompe Disease

✍ Scribed by Corrado Angelini; Claudio Semplicini

Book ID: 107545881
Publisher: Springer
Year: 2011
Tongue: English
Weight: 297 KB
Volume: 12
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-011-0236-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early administration of enzyme replaceme

Early administration of enzyme replacement therapy for Pompe disease: Short-term follow-up results

✍ M. A. Hamdan; M. H. Almalik; H. M. Mirghani 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 217 KB

Characterization of pre- and post-treatm

Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease

✍ Thurberg, Beth L; Lynch Maloney, Colleen; Vaccaro, Charles; Afonso, Kendra; Tsai 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 885 KB

Recombinant enzyme replacement therapy f

Recombinant enzyme replacement therapy for infantile-onset Pompe disease

✍ Michio Hirano 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 96 KB

Cardiac Remodeling After Enzyme Replacem

Cardiac Remodeling After Enzyme Replacement Therapy with Acid α-Glucosidase for Infants with Pompe Disease

✍ Jami C. Levine; Priya S. Kishnani; Y. T. Chen; J. Rene Herlong; Jennifer S. Li 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 308 KB

Enzyme replacement therapy induces T-cel

Enzyme replacement therapy induces T-cell responses in late-onset Pompe disease

✍ Miklos Banati; Zsolt Hosszu; Anita Trauninger; Laszlo Szereday; Zsolt Illes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

## Abstract ## Introduction: Enzyme replacement therapy (ERT) in ultra‐orphan Pompe disease generates anti‐rhGAA antibodies, which may interfere with efficacy. ## Methods: rhGAA‐specific T‐cell responses were examined at different time‐points in 6 Hungarian patients treated with rhGAA and compar

Fabry disease: enzyme replacement therap

Fabry disease: enzyme replacement therapy

✍ MR Bongiorno; G Pistone; M Aricò 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

## ABSTRACT Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an X‐linked lysosomal storage disorder caused by a deficiency of α‐galactosidase A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with α‐galacto